Using PPIX as a surrogate for tumor antigen in patients with primary and recurrent GBM, Bowman-Kirigin et al. observed that tumor antigen is phagocytosed by both CD141+ and CD1+ cDC subsets, which correspond to murine cDC1 and cDC2, respectively. This evidence concerns the gene THBD and neoplasm.